PE20180687A1 - Reactivos quirales para la preparacion de oligomeros homogeneos - Google Patents
Reactivos quirales para la preparacion de oligomeros homogeneosInfo
- Publication number
- PE20180687A1 PE20180687A1 PE2018000192A PE2018000192A PE20180687A1 PE 20180687 A1 PE20180687 A1 PE 20180687A1 PE 2018000192 A PE2018000192 A PE 2018000192A PE 2018000192 A PE2018000192 A PE 2018000192A PE 20180687 A1 PE20180687 A1 PE 20180687A1
- Authority
- PE
- Peru
- Prior art keywords
- preparation
- chiral reagents
- diastereomerically pure
- benzyl
- alkyl
- Prior art date
Links
- 239000012069 chiral reagent Substances 0.000 title 1
- SLRMQYXOBQWXCR-UHFFFAOYSA-N 2154-56-5 Chemical class [CH2]C1=CC=CC=C1 SLRMQYXOBQWXCR-UHFFFAOYSA-N 0.000 abstract 2
- MCKANBCWFDYIJO-UHFFFAOYSA-N chloro-dihydroxy-imino-$l^{5}-phosphane Chemical class NP(O)(Cl)=O MCKANBCWFDYIJO-UHFFFAOYSA-N 0.000 abstract 1
- CZZYITDELCSZES-UHFFFAOYSA-N diphenylmethane Chemical class C=1C=CC=CC=1CC1=CC=CC=C1 CZZYITDELCSZES-UHFFFAOYSA-N 0.000 abstract 1
- 239000002777 nucleoside Substances 0.000 abstract 1
- 150000003833 nucleoside derivatives Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7125—Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Abstract
SE REFIERE A COMPUESTOS FOSFORAMIDOCLORIDATO MORFONILO NUCLEOSIDOS ACTIVADOS DIASTEREOMERICAMENTE PUROS DE FORMULA (20), (22), (25), ENTRE OTROS, DONDE R1 Y R2 SON CADA UNO H, ALQUILO C1-C3, FENILO, ENTRE OTROS; R3 ES TRITILO OPCIONALMENTE SUSTITUIDO, BENCILO, DIFENILMETILO, ENTRE OTROS; R4 Y R5 SON CADA UNO -H, -C(O)R7 O C(O)OR7, EN DONDE R7 ES ALQUILO C1-C6, BENCILO, ENTRE OTROS. TAMBIEN SE REFIERE A UN METODO DE PREPARACION Y UNA COMPOSICION QUE COMPRENDE UN OLIGOMERO DIASTEREOMERICAMENTE PURO
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562201510P | 2015-08-05 | 2015-08-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20180687A1 true PE20180687A1 (es) | 2018-04-23 |
Family
ID=56943909
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2018000192A PE20180687A1 (es) | 2015-08-05 | 2016-08-05 | Reactivos quirales para la preparacion de oligomeros homogeneos |
Country Status (30)
| Country | Link |
|---|---|
| US (3) | US10457698B2 (es) |
| EP (2) | EP4039690A1 (es) |
| JP (3) | JP6978406B2 (es) |
| KR (1) | KR20180044303A (es) |
| CN (3) | CN108350005B (es) |
| AU (3) | AU2016302009B2 (es) |
| BR (2) | BR112018002430A2 (es) |
| CA (1) | CA2994842A1 (es) |
| CL (1) | CL2018000322A1 (es) |
| CO (1) | CO2018001615A2 (es) |
| DK (1) | DK3331891T3 (es) |
| ES (1) | ES2907629T3 (es) |
| HK (1) | HK1248708A1 (es) |
| HR (1) | HRP20220129T1 (es) |
| HU (1) | HUE057593T2 (es) |
| IL (3) | IL293066A (es) |
| LT (1) | LT3331891T (es) |
| MA (1) | MA44209B1 (es) |
| MD (1) | MD3331891T2 (es) |
| MX (2) | MX2018001557A (es) |
| MY (1) | MY196627A (es) |
| PE (1) | PE20180687A1 (es) |
| PH (1) | PH12018500265A1 (es) |
| PL (1) | PL3331891T3 (es) |
| PT (1) | PT3331891T (es) |
| RS (1) | RS62930B1 (es) |
| SI (1) | SI3331891T1 (es) |
| UA (1) | UA123995C2 (es) |
| WO (1) | WO2017024264A2 (es) |
| ZA (2) | ZA201801518B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108350005B (zh) * | 2015-08-05 | 2024-02-06 | 卫材R&D管理有限公司 | 用于制备均一低聚物的手性试剂 |
| WO2018057430A1 (en) | 2016-09-20 | 2018-03-29 | The Regents Of The University Of Colorado, A Body Corporate | Synthesis of backbone modified morpholino oligonucleotides and chimeras using phosphoramidite chemistry |
| IL294271A (en) | 2019-12-26 | 2022-08-01 | Nippon Shinyaku Co Ltd | Antisense nucleic acids that cause splicing on exon 50 |
| JPWO2021172498A1 (es) | 2020-02-28 | 2021-09-02 | ||
| US20240060068A1 (en) | 2020-12-11 | 2024-02-22 | Eisai R&D Management Co., Ltd. | Poly-morpholino oligonucleotide gapmers |
| AR124302A1 (es) | 2020-12-11 | 2023-03-15 | Eisai R&D Man Co Ltd | Gápmeros de oligonucleótidos de objetivo tau |
| IL307787A (en) | 2021-04-28 | 2023-12-01 | Eisai R&D Man Co Ltd | ANTISENSE OLIGONUCLEOTIDES and their use for the treatment of neurodegenerative disorders |
| WO2024010870A2 (en) * | 2022-07-07 | 2024-01-11 | Eisai R&D Management Co., Ltd. | Crystalline monomers for preparing antisense oligonucleotides and methods of their preparation and use |
| WO2024092256A2 (en) | 2022-10-27 | 2024-05-02 | Eisai R&D Management Co., Ltd. | Peptide-antisense oligonucleotides and their use for treatment of neurodegenerative disorders |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5185444A (en) | 1985-03-15 | 1993-02-09 | Anti-Gene Deveopment Group | Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages |
| US6117993A (en) * | 1995-05-23 | 2000-09-12 | Hybridon, Inc. | Synthons for oligonucleotide synthesis |
| US5922695A (en) | 1996-07-26 | 1999-07-13 | Gilead Sciences, Inc. | Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability |
| US5874554A (en) | 1996-12-13 | 1999-02-23 | Incyte Pharmaceuticals, Inc. | Methods and solvent vehicles for reagent delivery in oligonucleotide synthesis using automated pulse jetting devices |
| US6306599B1 (en) * | 1999-07-16 | 2001-10-23 | Agilent Technologies Inc. | Biopolymer arrays and their fabrication |
| EP1176151B1 (en) * | 2000-07-28 | 2014-08-20 | Agilent Technologies, Inc. | Synthesis of polynucleotides using combined oxidation/deprotection chemistry |
| AR036122A1 (es) | 2001-07-03 | 2004-08-11 | Avecia Biotechnology Inc | Un complejo de sal que comprende un n-alquilimidazol y una 1,1-dioxo-1,2-dihidro-1l6-benzo [d]-isotiazol-3-ona y un metodo para sintetizar oligonucleotidos utilizando la quimica de fosforamidita |
| CA2884340C (en) * | 2007-11-15 | 2017-07-25 | Sarepta Therapeutics, Inc. | Method of synthesis of morpholino oligomers |
| US8076476B2 (en) | 2007-11-15 | 2011-12-13 | Avi Biopharma, Inc. | Synthesis of morpholino oligomers using doubly protected guanine morpholino subunits |
| WO2011018798A2 (en) | 2009-08-14 | 2011-02-17 | Indian Association For The Cultivation Of Science | Morpholino-based antisense agent |
| CA2799501C (en) * | 2010-05-28 | 2022-02-15 | Sarepta Therapeutics, Inc. | Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups |
| RS55610B1 (sr) * | 2010-09-30 | 2017-06-30 | Nippon Shinyaku Co Ltd | Derivat morfolino nukleinske kiseline |
| US9161948B2 (en) | 2011-05-05 | 2015-10-20 | Sarepta Therapeutics, Inc. | Peptide oligonucleotide conjugates |
| KR102183273B1 (ko) * | 2011-05-05 | 2020-11-27 | 사렙타 쎄러퓨틱스, 인코퍼레이티드 | 펩타이드 올리고뉴클레오타이드 접합체 |
| TWI689513B (zh) | 2011-10-07 | 2020-04-01 | 美商基利科學股份有限公司 | 抗病毒核苷酸類似物的製備方法 |
| EA035030B1 (ru) | 2011-11-18 | 2020-04-20 | Сарепта Терапьютикс, Инк. | Модифицированные морфолиновые аналоги олигонуклеотидов |
| ES2832531T3 (es) | 2011-11-30 | 2021-06-10 | Sarepta Therapeutics Inc | Oligonucleótidos para el tratamiento de enfermedades por expansión de repeticiones |
| CN102702265A (zh) * | 2012-05-14 | 2012-10-03 | 天津特安化学科技有限公司 | 一种固相合成磷酰二胺吗啉代寡核苷酸及方法 |
| DE102015214943A1 (de) | 2015-08-05 | 2017-02-09 | Siemens Aktiengesellschaft | Verfahren und Anlage für eine chemische Synthese |
| MY188405A (en) | 2015-08-05 | 2021-12-08 | Janssen Biotech Inc | Anti-cd154 antibodies and methods of using them |
| GB201513921D0 (en) | 2015-08-05 | 2015-09-23 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers |
| CN108350005B (zh) * | 2015-08-05 | 2024-02-06 | 卫材R&D管理有限公司 | 用于制备均一低聚物的手性试剂 |
-
2016
- 2016-08-05 CN CN201680058501.2A patent/CN108350005B/zh active Active
- 2016-08-05 AU AU2016302009A patent/AU2016302009B2/en active Active
- 2016-08-05 MA MA44209A patent/MA44209B1/fr unknown
- 2016-08-05 SI SI201631470T patent/SI3331891T1/sl unknown
- 2016-08-05 IL IL293066A patent/IL293066A/en unknown
- 2016-08-05 WO PCT/US2016/045876 patent/WO2017024264A2/en active Application Filing
- 2016-08-05 PL PL16767053T patent/PL3331891T3/pl unknown
- 2016-08-05 ES ES16767053T patent/ES2907629T3/es active Active
- 2016-08-05 DK DK16767053.8T patent/DK3331891T3/da active
- 2016-08-05 PT PT167670538T patent/PT3331891T/pt unknown
- 2016-08-05 RS RS20220178A patent/RS62930B1/sr unknown
- 2016-08-05 KR KR1020187006255A patent/KR20180044303A/ko not_active Application Discontinuation
- 2016-08-05 MD MDE20180593T patent/MD3331891T2/ro unknown
- 2016-08-05 CA CA2994842A patent/CA2994842A1/en active Pending
- 2016-08-05 LT LTEPPCT/US2016/045876T patent/LT3331891T/lt unknown
- 2016-08-05 HR HRP20220129TT patent/HRP20220129T1/hr unknown
- 2016-08-05 PE PE2018000192A patent/PE20180687A1/es unknown
- 2016-08-05 US US15/750,087 patent/US10457698B2/en active Active
- 2016-08-05 HU HUE16767053A patent/HUE057593T2/hu unknown
- 2016-08-05 IL IL284611A patent/IL284611B2/en unknown
- 2016-08-05 BR BR112018002430-9A patent/BR112018002430A2/pt active Search and Examination
- 2016-08-05 MX MX2018001557A patent/MX2018001557A/es unknown
- 2016-08-05 UA UAA201802109A patent/UA123995C2/uk unknown
- 2016-08-05 EP EP21210674.4A patent/EP4039690A1/en active Pending
- 2016-08-05 CN CN202410065464.4A patent/CN117924364A/zh active Pending
- 2016-08-05 EP EP16767053.8A patent/EP3331891B1/en active Active
- 2016-08-05 CN CN202110735306.1A patent/CN113461733A/zh active Pending
- 2016-08-05 BR BR122023025447-3A patent/BR122023025447A2/pt unknown
- 2016-08-05 JP JP2018506149A patent/JP6978406B2/ja active Active
- 2016-08-25 MY MYPI2018000173A patent/MY196627A/en unknown
-
2018
- 2018-02-05 CL CL2018000322A patent/CL2018000322A1/es unknown
- 2018-02-05 PH PH12018500265A patent/PH12018500265A1/en unknown
- 2018-02-05 IL IL257353A patent/IL257353B2/en unknown
- 2018-02-06 MX MX2022000124A patent/MX2022000124A/es unknown
- 2018-02-19 CO CONC2018/0001615A patent/CO2018001615A2/es unknown
- 2018-03-05 ZA ZA2018/01518A patent/ZA201801518B/en unknown
- 2018-06-26 HK HK18108188.5A patent/HK1248708A1/zh unknown
-
2019
- 2019-08-15 ZA ZA2019/05394A patent/ZA201905394B/en unknown
- 2019-09-17 US US16/573,185 patent/US10836784B2/en active Active
-
2020
- 2020-10-28 US US17/082,070 patent/US20210171555A1/en active Pending
-
2021
- 2021-09-29 JP JP2021159804A patent/JP7254869B2/ja active Active
- 2021-12-21 AU AU2021290235A patent/AU2021290235B2/en active Active
-
2023
- 2023-03-29 JP JP2023053119A patent/JP2023085402A/ja active Pending
- 2023-09-08 AU AU2023226763A patent/AU2023226763A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20180687A1 (es) | Reactivos quirales para la preparacion de oligomeros homogeneos | |
| CO2017008403A2 (es) | Derivados de nucleósidos sustituidos útiles como agentes antineoplásicos | |
| AR125320A2 (es) | Compuesto cristalino, método de preparación y composición que lo comprende | |
| CL2018003504A1 (es) | Derivados de carbonucleósidos sustituidos útiles como agentes antineoplasicos. | |
| ES2770058T3 (es) | Compuestos y composiciones destinados a modular las actividades de quinasa de EGFR mutante | |
| UY36838A (es) | Compuestos heterocíclicos moduladores de la señalización de tnf alfa y composiciones farmacéuticas que los contienen | |
| CL2017002813A1 (es) | Proceso para preparar 4-amino-piridazinas | |
| ES2723355T3 (es) | Métodos útiles en la síntesis de análogos de halicondrina B | |
| ECSP16012693A (es) | Polipéptido para la escisión hidrolítica de la zearalenona y/o derivados de la zearalenona, polinucleótido aislado de la misma y polipéptido que contiene aditivo, uso y procedimiento de los mismos | |
| EA201792503A1 (ru) | Соль (s)-kck s-кетамина, соль (r)-kck s-кетамина и способы получения s-кетамина | |
| EA201890648A2 (ru) | Диоксолановые аналоги уридина для лечения рака | |
| CO2017001178A2 (es) | Derivado de piridona que tiene un grupo tetrahidropiranil metilo | |
| PE20170946A1 (es) | 2-amino-6-(difluorometil)- 5,5-difluoro-6-fenil-3,4,5,6-tetrahidropiridinas como inhibidores de bace1 | |
| CO2017002253A2 (es) | Compuesto dirigido a il-23a y tnf-alfa | |
| DOP2017000120A (es) | 4-oxo-3,4-dihidro-1,2,3-benzotriazinas como moduladores de gpr139 | |
| EA201790570A1 (ru) | Модуляторы р2х7 | |
| CR20170438A (es) | Desacetoxitubulisina h y análogos de esta | |
| PE20180252A1 (es) | Moduladores alostericos positivos del receptor muscarinico m2 | |
| PE20190979A1 (es) | Compuestos de heteroarilcarboxamida como inhibidores de ripk2 | |
| PE20181352A1 (es) | Compuestos heterociclicos que contienen bencilamina y composiciones utiles contra infeccion por micobacterias | |
| AR104731A1 (es) | Benzamidas sustituidas y métodos para utilizarlas | |
| CL2019000662A1 (es) | Inhibidores de dopamina–b–hidroxilasa. | |
| CR20170005A (es) | Derivados de insoindolina | |
| PE20211780A1 (es) | Compuestos de pirimidinodiona biciclicos sustituidos con tetrahidropirano (thp) | |
| BR112017004925A2 (pt) | composição e método |